Editorial
doi: 10.1093/infdis/jir144.
Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
- PMID: 21592979
- PMCID: PMC3096788
- DOI: 10.1093/infdis/jir144
Item in Clipboard
Editorial
Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
J Infect Dis.
.
No abstract available
Comment on
-
Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.J Infect Dis. 2011 Jun 1;203(11):1534-41. doi: 10.1093/infdis/jir138. J Infect Dis. 2011. PMID: 21592981 Free PMC article.
Similar articles
-
Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14. Vaccine. 2014. PMID: 24837782 Free PMC article.
-
Vaccination against the human cytomegalovirus.Vaccine. 2019 Nov 28;37(50):7437-7442. doi: 10.1016/j.vaccine.2018.02.089. Epub 2018 Apr 3. Vaccine. 2019. PMID: 29622379 Free PMC article. Review.
-
A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.J Virol. 2019 Nov 13;93(23):e00747-19. doi: 10.1128/JVI.00747-19. Print 2019 Dec 1. J Virol. 2019. PMID: 31511385 Free PMC article. Clinical Trial.
-
Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.J Infect Dis. 2004 Apr 15;189(8):1374-81. doi: 10.1086/382751. Epub 2004 Apr 1. J Infect Dis. 2004. PMID: 15073673
-
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.J Virol. 2018 Mar 14;92(7):e00030-18. doi: 10.1128/JVI.00030-18. Print 2018 Apr 1. J Virol. 2018. PMID: 29343580 Free PMC article. Review.
Cited by
-
Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448. Viruses. 2014. PMID: 24473341 Free PMC article.
-
Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.J Pediatric Infect Dis Soc. 2016 Mar;5(1):14-20. doi: 10.1093/jpids/piu089. Epub 2014 Sep 11. J Pediatric Infect Dis Soc. 2016. PMID: 26908487 Free PMC article.
-
Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.Hum Vaccin Immunother. 2012 Nov 1;8(11):1595-606. doi: 10.4161/hv.21225. Epub 2012 Aug 24. Hum Vaccin Immunother. 2012. PMID: 22922766 Free PMC article.
-
Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14. Vaccine. 2014. PMID: 24837782 Free PMC article.
-
Cytomegalovirus in the neonate: immune correlates of infection and protection.Clin Dev Immunol. 2013;2013:501801. doi: 10.1155/2013/501801. Epub 2013 Aug 19. Clin Dev Immunol. 2013. PMID: 24023565 Free PMC article. Review.
References
-
- Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76. - PubMed
-
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63. - PubMed
-
- Bale JF, Miner L, Petheram SJ. Congenital cytomegalovirus infection. Curr Treat Options Neurol. 2002;4:225–30. - PubMed
-
- Williamson WD, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics. 1992;90:862–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
